Glycomet-GP 0.5 Tablet SR
By Glycomet-GP
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(0.5mg) + Metformin(500mg)

Manufacturer - USV Ltd
Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai - 400 088. , India.

Expires on or after
July, 2026

liver
The use of Glycomet-GP 0.5 Tablet SR should be approached with caution in individuals with liver disease. It may be necessary to adjust the dosage of Glycomet-GP 0.5 Tablet SR in such cases. It is advisable to seek guidance from a medical professional before starting this medication. Typically, treatment with Glycomet-GP 0.5 Tablet SR commences at a low dose for patients with mild to moderate liver conditions. However, it is not advisable to use this medication in individuals with severe liver disease. Remember to consult your doctor for personalized advice based on your specific liver health status.

kidney
Caution should be taken when using Glycomet-GP 0.5 Tablet SR in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for those with severe kidney issues. Regular kidney function monitoring is advised during treatment.

alcohol
It is unsafe to drink alcohol while taking Glycomet-GP 0.5 Tablet SR. Avoid consuming alcohol with this medication.

driving
"Caution when driving Avoid driving if experiencing symptoms of low or high blood sugar."

pregnancy
Glycomet-GP 0.5 Tablet SR is considered unsafe during pregnancy. Limited human studies suggest potential harm to the developing baby. Your doctor will evaluate benefits and risks before prescribing. Consult your doctor.

breastfeeding
Glycomet-GP 0.5 Tablet SR is not safe to use while breastfeeding, as it may cause harm to the baby due to potential toxicity.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹58.25
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024